A detailed history of Advisory Services Network, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Advisory Services Network, LLC holds 184,361 shares of AUPH stock, worth $1.76 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
184,361
Previous 184,361 -0.0%
Holding current value
$1.76 Million
Previous $1.05 Million 28.42%
% of portfolio
0.03%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$4.81 - $5.78 $8,316 - $9,993
-1,729 Reduced 0.93%
184,361 $1.05 Million
Q1 2024

May 06, 2024

SELL
$4.93 - $9.31 $14,479 - $27,343
-2,937 Reduced 1.55%
186,090 $932,000
Q4 2023

Feb 09, 2024

SELL
$7.13 - $9.49 $5,461 - $7,269
-766 Reduced 0.4%
189,027 $1.7 Million
Q3 2023

Nov 14, 2023

BUY
$7.77 - $12.27 $98,624 - $155,743
12,693 Added 7.17%
189,793 $1.47 Million
Q2 2023

Aug 09, 2023

SELL
$8.96 - $11.69 $174,746 - $227,990
-19,503 Reduced 9.92%
177,100 $1.71 Million
Q1 2023

May 17, 2023

BUY
$5.94 - $11.27 $264,377 - $501,605
44,508 Added 29.26%
196,603 $2.15 Million
Q4 2022

Feb 13, 2023

SELL
$4.11 - $8.14 $150,483 - $298,037
-36,614 Reduced 19.4%
152,095 $657,000
Q3 2022

Nov 14, 2022

SELL
$6.66 - $12.39 $427,685 - $795,648
-64,217 Reduced 25.39%
188,709 $1.42 Million
Q2 2022

Aug 02, 2022

BUY
$8.95 - $12.8 $8,502 - $12,160
950 Added 0.38%
252,926 $2.54 Million
Q1 2022

May 23, 2022

BUY
$10.05 - $22.48 $2.53 Million - $5.66 Million
251,976 New
251,976 $3.12 Million
Q2 2019

Aug 01, 2019

SELL
$6.05 - $6.75 $3,025 - $3,375
-500 Closed
0 $0
Q1 2019

May 20, 2019

BUY
$6.06 - $7.64 $3,030 - $3,820
500 New
500 $3,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.36B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.